Who are the leading innovators in Blood Glucose Sensors for Medical Devices Industry? | So Good News
The medical device industry remains a hotbed of innovation, driven by the importance of technologies such as home care, preventative care, early diagnosis, shorter patient recovery times and improved outcomes, as well as machine learning and augmented reality. , 5G and digitization. According to GlobalData’s Internet of Things in Medical Devices: Blood Glucose Sensors report, more than 450,000 patents have been filed and filed in the medical device industry in the last three years alone.
However, not all innovations are the same and they do not follow a constant growth trend. Instead, their evolution takes the form of an S-shaped curve, showing their typical life cycle from early emergence to accelerated adoption and finally to stabilization and maturity.
Determining where a particular innovation is on this journey, especially those in the emerging and accelerating stages, is critical to understanding their current level of adoption and their likely future trajectory and impact.
150+ innovations are shaping the medical device industry
According to GlobalData Technology Foresights, which plots the S-curve for the medical device industry using innovation intensity models based on more than 550,000 patents, there are 150+ innovation areas shaping the future of the industry.
inside to appear stage of innovation, ingestible sensors, wireless gastric stimulation devices, and remote nerve stimulation devices are disruptive technologies that are in their infancy and should be closely monitored. Dose control inhalers, programmable infusion pumps and sports monitoring sensors are some. acceleration innovative industries whose adoption is steadily increasing. between maturity Innovative areas are blood glucose sensors and medical emergency response systems, which are now well established in the industry.
The Innovation S-Curve for the Internet of Things in the Medical Device Industry
Blood glucose sensors is a key innovative area in the Internet of Things
A sensor used in a glucose monitor is placed under the skin to continuously measure blood glucose levels. The sensor checks glucose every few minutes during the day and night. This helps prevent low/high blood glucose emergencies and reduces finger pricks. It is inserted by the user and must be replaced with a new disposable sensor every seven to ten days.
GlobalData’s analysis also reveals the companies at the forefront of each innovative area and assesses the potential reach and impact of their patenting activities in different applications and geographies. According to GlobalData, there are more than 50 companies involved in the development and deployment of blood glucose sensors, including technology vendors, established medical device companies and up-and-coming startups.
Key players in blood glucose sensors are innovation in medical devices industry
“Application diversity” measures the number of different applications identified for each relevant patent and broadly divides companies into “niche” or “diversified” innovators.
“Geographic reach” refers to the number of different countries in which each relevant patent is registered and indicates the range of geographic application, ranging from “global” to “local”.
F.Hoffmann La-Roche is one of the leading patentees in the field of blood glucose sensors. Some other major patentees in this field include Medtronic and PHC Holdings.
In terms of application diversity, Cue Health leads the pack, followed by Dare Bioscience and Apple. In terms of geographic reach, Bionime holds the first position, followed by Johnson & Johnson and Apple in the second and third positions, respectively.
The increasing prevalence of obesity and diabetes and ease of use improve the future prospects of these devices. However, development should focus on educating endocrinologists in the use of these devices and making the sensors reusable to ensure long-term benefits.
Access GlobalData’s latest Topical Research Report on Medical Devices for a deeper understanding of the key themes and technologies disrupting the medical device industry.